You probably know someone with heart disease, Alzheimer’s, or type 2 diabetes. With iMBP, you have the power to directly impact how we develop drugs and help find effective solutions to help loved ones and families affected by these debilitating illnesses. You can be part of the solution.
Today’s developmental process for new, lifesaving drugs is complex, expensive, and time-consuming. The current industry solution is to simply spend more money, resulting in over-expensive therapeutics with marginal benefits. These deficiencies of cause burden on the people who need these therapeutic solutions most.
Our solution - the development of iPlatform™, our proprietary computational approach that uses in-silico therapeutic discovery and molecular design to improve upon traditional biotechnology. This creates both economic and time-saving advantages to drug discovery, allowing for life-saving solutions to potentially reach the clinic faster and more affordably.
According to Alzheimer’s Association, in 2018, an estimated 5.7 million people in the United States who are aged 65 or older are living with AD. By 2050, this number is predicted to increase to approximately 14 million.
According to the World Health Organization, an estimated 50 million people worldwide currently have dementia, and there are nearly 10 million new cases every year; Alzheimer disease affects about 60-70% of them.
Cardiovascular disease remains the leading cause of death across the globe, according to a new “almanac”-style special issue of the Journal of the American College of Cardiology (JACC). High blood pressure, high cholesterol, dietary risks and air pollution were the leading causes of CVD worldwide.
High systolic blood pressure remains the leading modifiable risk factor for premature CV deaths, accounting for 10.8 million CV deaths and 11.3 million deaths overall in 2021*.
According to the WHO, about 422 million people worldwide have diabetes, with over 95% of people suffering of type 2 diabetes. 1.5 million deaths are directly attributed to diabetes each year.
- Adults with diabetes have a two- to three-fold increased risk of heart attacks and strokes.
- Close to 1 million people are blind due to diabetes.
- Diabetes is among the leading causes of kidney failure
By investing today, you’re giving communities the opportunity to invest in their own heath while improving the ways drugs are discovered.